Dr. Steven Messe, MD
Claim this profileHospital of the University of Pennsylvania
Studies Stroke
Studies Sleep Apnea
3 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials Steven Messe, MD is currently running
CPAP
for Sleep Apnea After Stroke
The purpose of this study is to determine whether treatment of obstructive sleep apnea (OSA) with positive airway pressure starting shortly after acute ischemic stroke (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke.
Recruiting1 award N/A1 criteria
Tissue Kallikrein
for Ischemic Stroke
This is a Phase 2/3 study evaluating the safety and efficacy of DM199 (rinvecalinase alfa) in treating participants with moderate stroke severity, who present within 24 hours of Acute Ischemic Stroke (AIS) onset due to small and medium vessel occlusions. This study focuses on participants with limited treatment options. Participants who have or will receive mechanical thrombectomy (MT) are not eligible for participation. Additionally, participants who have received fibrinolytics are excluded unless they experience a persistent neurological deficit of moderate severity six or more hours after fibrinolytic treatment. Participants considered for this trial should not be denied the use of standard of care (SoC) AIS therapies, such as fibrinolytics or MT, when appropriate. The double-blinded study will be randomized and placebo-controlled at up to approximately 100 sites.
Recruiting0 awards Phase 2 & 37 criteria
More about Steven Messe, MD
Clinical Trial Related6 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Steven Messe, MD has experience with
- Nitric Oxide
- CPAP
- Recombinant Human Tissue Kallikrein
Breakdown of trials Steven Messe, MD has run
Stroke
Sleep Apnea
Obstructive Sleep Apnea Syndrome
Multicenter Trial
Randomized Clinical Trial
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Steven Messe, MD specialize in?
Steven Messe, MD focuses on Stroke and Sleep Apnea. In particular, much of their work with Stroke has involved treating patients, or patients who are undergoing treatment.
Is Steven Messe, MD currently recruiting for clinical trials?
Yes, Steven Messe, MD is currently recruiting for 2 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Steven Messe, MD has studied deeply?
Yes, Steven Messe, MD has studied treatments such as Nitric Oxide, CPAP, Recombinant human tissue kallikrein.
What is the best way to schedule an appointment with Steven Messe, MD?
Apply for one of the trials that Steven Messe, MD is conducting.
What is the office address of Steven Messe, MD?
The office of Steven Messe, MD is located at: Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104 United States. This is the address for their practice at the Hospital of the University of Pennsylvania.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.